Evaluating benefits and harms in intensive care research

Intensive Care Medicine

Volumn 33, Issue 10, 2007, Pages 1819-1822

  Weijer, Charles ^a   Miller, Paul B ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; CLINICAL OBSERVATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL RESEARCH; HEALTH HAZARD; HEALTH PRACTITIONER; INFORMED CONSENT; INTENSIVE CARE; MEDICAL CARE; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL RECORD REVIEW; PATIENT CARE; PATIENT PARTICIPATION; RESEARCH ETHICS; RESEARCH SUBJECT; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SCIENCE; WELLBEING;

HEALTH SERVICES RESEARCH; HUMAN EXPERIMENTATION; HUMANS; INTENSIVE CARE; RISK ASSESSMENT;

EID: 34748863659     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0818-5     Document Type: Review

References (13)

1. Steinbrook R (2003) How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome. N Engl J Med 348:1393-1401
2. Directive 2001/20/EC (Clinical Trials Directive). Website: http://europa.eu.int/eur-lex/pri/en/oj/dat/2001/l_121/l_12120010501en00340044. pdf. Date accessed: June 3, 2007
3. Truog RD (2005) Will ethical requirements bring critical care research to a halt? Intensive Care Med 31:338-344
4. Weijer C (2005) Is clinical research and ethics a zero sum game? Critical Care Med 33:912-913
5. U.S. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report. Website: http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm. Date accessed: June 3, 2007
6. World Medical Association. Declaration of Helsinki. Website: http://www.wma.net/e/policy/b3.htm. Date accessed: June 3, 2007
7. Miller FG, Brody H (2003) A critique of clinical equipoise: therapeutic misconception in the ethics of clinical trials. Hastings Center Report 33:19-28
8. Miller PB, Weijer C (2007) Evaluating benefits and harms in clinical research. In: Ashcroft R, Dawson A, Draper H, McMillan J (eds) Principles of health care ethics, 2nd edn. Wiley, London, pp 711-717
9. Weijer C, Miller PB (2004) When are research risks reasonable in relation to anticipated benefits? Nat Med 10:570-573
10. Emanuel EJ, Wendler D, Grady C (2000) What makes clinical research ethical? JAMA 283:2701-2711
11. U.S. National Bioethics Advisory Commission (NBAC) (2000) Ethical and policy issues in research involving human participants. NBAC, Bethesda, MD, pp 69-96. Website: http://bioethics.georgetown.edu/nbac/human/overvol1.html. Date accessed: June 4, 2007
12. Liddell K, Bion J, Chamberlain D, Druml C, Kompanje E, Lemaire F, Menon D, Vrhovac B, Wiedermann CJ (2006) Medical research involving incapacitated adults: implications of the EU Clinical Trials Directive 2001/20/EC. Med Law Rev 14:367-417
13. McRae AD, Ackroyd-Stolarz S, Weijer C (2005) Risk in emergency research using a waiver of/exception from consent: implications of a structured approach for IRB review. Acad Emerg Med 12:1104-1112